<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122696">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01903772</url>
  </required_header>
  <id_info>
    <org_study_id>IMTCO</org_study_id>
    <secondary_id>Schön Klinik BGL</secondary_id>
    <nct_id>NCT01903772</nct_id>
  </id_info>
  <brief_title>Effects of Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <acronym>IMTCO</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Berchtesgadener Land der Schön-Kliniken</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Berchtesgadener Land der Schön-Kliniken</source>
  <oversight_info>
    <authority>Germany: The Bavarian State Ministry of the Environment and Public Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The additional effect of inspiratory muscle training as an adjunct to a general exercise
      training program in patients with COPD with inspiratory muscle weakness will be studied. The
      main hypothesis is that inspiratory muscle training combined with an exercise training
      program improves functional exercise capacity more than an exercise training program without
      the addition of an inspiratory muscle training program.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>6-Minute walking distance</measure>
    <time_frame>change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>exercise capacity (constant work rate test)</measure>
    <time_frame>change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximal inspiratory pressure (PImax)</measure>
    <time_frame>change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inspiratory muscle endurance capacity</measure>
    <time_frame>change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dyspnea</measure>
    <time_frame>change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured via Borg-scale at rest, during 6-minute walking distance, during constant work rate test at iso-time, during inspiratory muscle endurance capacity test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>COPD</condition>
  <condition>Inspiratory Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Inspiratory Muscle Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure: Inspiratory Muscle Training Three times daily inspiratory muscle training (2x30 breaths) at an intensity of &gt;50% Pi,max</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Inspiratory Muscle Training</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Twice daily inspiratory muscle training (3x30 breaths) at an intensity of 5 centimeters of water (H2O)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inspiratory Muscle Training</intervention_name>
    <arm_group_label>Inspiratory Muscle Training</arm_group_label>
    <arm_group_label>Sham Inspiratory Muscle Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with COPD

          -  Eligible to participate in an inpatient pulmonary rehabilitation program of 3 weeks

          -  Pi,max &lt;60 centimeters of water or &lt;50% of the predicted normal value

        Exclusion Criteria:

          -  Major comorbidities preventing successful participation in an 8 week exercise
             training intervention

          -  use of non-invasive ventilation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Schön Klinik Berchtesgadener Land</name>
      <address>
        <city>Schönau am Königssee</city>
        <state>Bayern</state>
        <zip>83483</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Gloeckl, MSc.</last_name>
      <phone>+49 8652 931630</phone>
      <email>rgloeckl@schoen-kliniken.de</email>
    </contact>
    <contact_backup>
      <last_name>Kenn Klaus, MD</last_name>
      <phone>+49 8652931541</phone>
      <email>kkenn@schoen-kliniken.de</email>
    </contact_backup>
    <investigator>
      <last_name>Klaus Kenn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 16, 2013</lastchanged_date>
  <firstreceived_date>July 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Berchtesgadener Land der Schön-Kliniken</investigator_affiliation>
    <investigator_full_name>Klaus Kenn</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Asthenia</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Paresis</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
